The university announced Michael E. Kupferman as the new CEO of Penn State Health on Wednesday, May 28. His selection comes from a committee composed of leaders from Penn State Health and the College of Medicine.
Kupferman will succeed interim CEO Deborah Addo and oversee the $4.2 billion health system, which collaborates with Penn State College of Medicine and other university leaders to align clinical and academic operations.
A board-certified head and neck cancer surgeon, Kupferman earned his medical degree from the University of Pennsylvania Perelman School of Medicine. He completed surgical training at the Hospital of the University of Pennsylvania and also holds an MBA from Northwestern University’s Kellogg School of Management.
In a university press release, Kupferman said he looks forward to “working shoulder to shoulder with my talented and dedicated colleagues at Penn State Health and the College of Medicine to deliver on our promise to provide unparalleled and innovative care to the people of Central Pennsylvania and the commonwealth.”
Kupferman previously served as president of the Banner University Medicine Division and led various programs at MD Anderson Cancer Center. He will assume his new role as CEO on June 23.
MORE CAMPUS COVERAGE
7 Commonwealth campuses are slated to close by spring 2027 following a 25-8 vote from Penn S…